FirstCry-Backed Swara Baby Products Gains Sebi Approval for ₹1,000 Cr IPO

Swara Baby Products Secures SEBI Approval for ₹1,000 Crore IPO

The approval marks a significant milestone for the hygiene products manufacturer as it prepares for its market debut.

IPO Structure and Utilization of Proceeds

The upcoming IPO consists of a fresh issue of equity shares worth ₹500 crore and an equal-sized offer for sale (OFS). The OFS will see Brainbees Solutions Ltd selling shares valued at ₹300 crore, while Anadya Bon Merchari LLP will contribute ₹200 crore. The funds raised from the fresh issue will primarily be allocated towards setting up a new manufacturing facility in Madhya Pradesh, with ₹198.2 crore earmarked for this purpose. Additionally, ₹100 crore will go towards repaying existing borrowings, and ₹27.5 crore will be invested in subsidiaries to manage their outstanding debts.

Company Overview and Market Position

Founded in 2018, Swara Baby Products specializes in manufacturing disposable hygiene products, including baby diapers, adult diapers, and feminine hygiene items. The company operates four manufacturing facilities in Madhya Pradesh and has established a robust supply chain, catering to notable clients such as Brainbees Solutions, Piramal Pharma, and Himalaya Wellness Company. Swara Baby also markets its own brands, Cuddles and Shield, through various retail channels, enhancing its visibility in the competitive hygiene market.

Financial Performance and Growth Prospects

For the fiscal year 2026, Swara Baby reported a revenue of ₹1,163.9 crore, a notable increase from ₹942.97 crore in FY25. The company’s profit after tax also saw a rise, reaching ₹95.58 crore compared to ₹80.67 crore the previous year. This growth trajectory underscores the increasing demand for hygiene products and the company’s ability to capitalize on market opportunities.

Strategic Plans and Future Outlook

The IPO proceeds will not only facilitate the establishment of a new manufacturing facility but also support Swara Baby’s plans for inorganic growth through potential acquisitions. The company is also considering a pre-IPO placement of up to ₹100 crore, which could further bolster its financial position ahead of the public offering. With a strong backing from FirstCry and a growing portfolio, Swara Baby is well-positioned to enhance its market presence.

Key Highlights

• Swara Baby Products has received SEBI approval for a ₹1,000 crore IPO.
• The IPO includes a fresh issue of ₹500 crore and an equal-sized offer for sale.
• Proceeds will fund a new manufacturing facility and repay existing debts.
• The company reported a revenue increase to ₹1,163.9 crore in FY26.
• Plans for inorganic growth through acquisitions are underway.

Investor Note: The upcoming IPO presents an opportunity for investors to engage with a rapidly growing hygiene products manufacturer. With strong financial performance and strategic expansion plans, Swara Baby Products could be a compelling addition to investment portfolios focused on consumer goods.